CAPD in patients with autosomal dominant polycystic kidney disease

被引:6
|
作者
Hadimeri, H
Johansson, AC
Haraldsson, B
Nyberg, G [1 ]
机构
[1] Sahlgrenska Univ Sjukhuset, Transplant Unit, S-41345 Gothenburg, Sweden
[2] Sahlgrenska Univ Sjukhuset, Dept Nephrol, S-41345 Gothenburg, Sweden
来源
PERITONEAL DIALYSIS INTERNATIONAL | 1998年 / 18卷 / 04期
关键词
autosomal dominant PKD; dialysis efficacy; hernia; peritonitis;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: To investigate whether there are specific complications to continuous ambulatory peritoneal dialysis (CAPD) in patients with autosomal dominant polycystic kidney disease (ADPKD) due to defects in various wall structures - causing hernia and diverticulitis - and to enlarged kidneys. Design:The clinical experience of CAPD in 26 patients with ADPKD, treated for 11 +/- 6 months, was studied in retrospect and compared with that of 26 contemporary controls. Medical records were reviewed with respect to survival in this treatment form and any complication. Peritoneal dialysis capacity (PDC), as measured in 21 ADPKD patients and 20 controls, was also evaluated. Setting: University Hospital. Results: Before initiation of CAPD, enlarged kidneys necessitated nephrectomy in 2 of 26 ADPKD patients; both cases were registered as preparation for transplantation, not for CARD. Survival in CAPD was similar in ADPKD patients and controls. Hernia was present in 4 ADPKD patients and 2 controls, and required transfer to hemodialysis in 1 patient from each group, temporarily. The incidence of peritonitis was I per 20 months in ADPKD patients versus 1 in 27 months in the controls, not significantly different. Peritonitis was caused by colonic bacteria in similar numbers. Residual renal function was 1.9 +/- 2.1 mL/min per 1.73 m(2) in ADPKD patients versus 1.9 +/- 1.4 mllmin per 1.73 m(2) in the controls. No difference was detected in any of the variables measured by PDC. Conclusion: There were no specific problems related to ADPKD.
引用
收藏
页码:429 / 432
页数:4
相关论文
共 50 条
  • [31] Management of ESRD in Patients With Autosomal Dominant Polycystic Kidney Disease
    Alam, Ahsan
    Perrone, Ronald D.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2010, 17 (02) : 164 - 172
  • [32] LAPAROSCOPIC NEPHRECTOMY IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    Sharapov, Olimkhon
    Abdullaev, Sherzod
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1235 - I1235
  • [33] Evaluation of Nephrolithiasis in Autosomal Dominant Polycystic Kidney Disease Patients
    Nishiura, Jose L.
    Neves, Rodrigo F. C. A.
    Eloi, Samara R. M.
    Cintra, Susan M. L. F.
    Ajzen, Sergio A.
    Heilberg, Ita P.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (04): : 838 - 844
  • [34] α-lipoic acid in patients with autosomal dominant polycystic kidney disease
    Lai, Silvia
    Petramala, Luigi
    Muscaritoli, Maurizio
    Cianci, Rosario
    Mazzaferro, Sandro
    Mitterhofer, Anna Paola
    Pasquali, Marzia
    D'Ambrosio, Viola
    Carta, Maria
    Ansuini, Matteo
    Ramaccini, Cesarina
    Galani, Alessandro
    Amabile, Maria Ida
    Molfino, Alessio
    Letizia, Claudio
    NUTRITION, 2020, 71
  • [35] LAPAROSCOPIC NEPHRECTOMY IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    Reznik, O. N.
    Ananiev, A. N.
    Nevirovich, E. S.
    Daineko, V. S.
    Skvortsov, A. E.
    Kutenkov, A. A.
    Kuzmin, D. O.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2016, 18 (03): : 50 - 56
  • [36] Coronary aneurysms in patients with autosomal dominant polycystic kidney disease
    Hadimeri, H
    Lamm, C
    Nyberg, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1998, 9 (05): : 837 - 841
  • [37] Uroflowmetry alterations in patients with autosomal dominant polycystic kidney disease
    Lai, S.
    Mittherhofer, A. P.
    Cianci, R.
    Riviello, L.
    Vocaturi, M.
    Mastroluca, D.
    Ciccariello, M.
    Von Heland, M.
    Ricciuti, G. P.
    Salciccia, S.
    Mazzaferro, S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (07) : 2734 - 2743
  • [38] Mortality risk in patients with autosomal dominant polycystic kidney disease
    Deirdre Mladsi
    Xiaolei Zhou
    Gregory Mader
    Myrlene Sanon
    Jinyi Wang
    Christine Barnett
    Cynthia Willey
    Stephen Seliger
    BMC Nephrology, 25
  • [39] Complications of autosomal dominant polycystic kidney disease in hemodialysis patients
    Norby, SM
    Torres, VE
    SEMINARS IN DIALYSIS, 2000, 13 (01) : 30 - 35
  • [40] Optimal care of autosomal dominant polycystic kidney disease patients
    Schrier, RW
    NEPHROLOGY, 2006, 11 (02) : 124 - 130